Manufactured by Pfizer, Neurontin® (generically referred to as gabapentin) is an anti-convulsant medication that was first approved for the treatment of epilepsy by the U.S. Food and Drug Administration (FDA) in 1994. Later in 2002, the FDA also approved Neurontin® for the treatment of various types of nerve pain. Interestingly, a controversial method of reducing addiction to methamphetamine, cocaine and alcohol also relies on the use of Neurontin® as part of a drug therapy to curb withdrawal symptoms.
Although Neurontin® has been proven to effectively treat a range of conditions, it is also known to cause some rare but life-threatening side effects, including liver toxicity, suicidal thoughts or action, and a skin reaction, Stevens-Johnson syndrome.
Neurontin® patients who are diagnosed with Stevens-Johnson syndrome or any adverse effect may qualify to seek compensation from Pfizer. Patients who are eligible may be able to collect compensation for their medical bills, lost wages, permanent disabilities, pain and suffering. Our Stevens-Johnson syndrome attorneys welcome victims to attend a free initial consultation. We will evaluate the specific details of your case to determine if you are eligible and the best way to proceed.
We provide free case evaluations for all patients who believe they may have a claim.
Given the severity of some of Neurontin®'s side effects, it's essential that patients familiarize themselves with the range of potential side effects, along with their associated symptoms. In terms of Stevens-Johnson syndrome, specifically, patients may start to experience any combination of:
Neurontin® patients who begin to experience these symptoms should seek emergency medical attention for a thorough exam and an official diagnosis. To confirm or rule out the presence of Stevens-Johnson syndrome, doctors may perform a comprehensive physical exam, as well as a skin tissue biopsy. Patients who catch and treat SJS in its early stages will have the best chances for the most favorable outcomes.